CardioBreak: Low-Risk TAVR Trial, Living Kidney Donor Risk, State Standards
MedPage Today,
savesaved The PARTNER III trial for transcatheter aortic valve replacement (TAVR) in low-risk patients has been cleared by the…
savesaved The PARTNER III trial for transcatheter aortic valve replacement (TAVR) in low-risk patients has been cleared by the…
Credit: Shutterstock In the past 15 years, clinicians have developed scientific "calculators" to predict long-term outcomes for…
In the past 15 years, clinicians have developed scientific “calculators” to predict long-term outcomes for patients with…